Cancer targeting with biomolecules: A comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles

Photochemical and Photobiological Sciences

Volumn 14, Issue 4, 2015, Pages 737-747

  Obaid, Girgis ^a   Chambrier, Isabelle ^a   Cook, Michael J ^a   Russell, David A ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GOLD DERIVATIVE; INDOLE DERIVATIVE; LECTIN; MACROGOL DERIVATIVE; METAL NANOPARTICLE; MONOCLONAL ANTIBODY; ORGANOMETALLIC COMPOUND; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; SINGLET OXYGEN; TUMOR ANTIGEN; ZN(II)-PHTHALOCYANINE;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DRUG EFFECTS; HUMAN; IMMUNOLOGY; LYSOSOME; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; TUMOR CELL LINE;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; GOLD COMPOUNDS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INDOLES; LECTINS; LYSOSOMES; METAL NANOPARTICLES; MOLECULAR TARGETED THERAPY; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYETHYLENE GLYCOLS; RECEPTOR, ERBB-2; SINGLET OXYGEN;

EID: 84926483186     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/c4pp00312h     Document Type: Article

References (46)

1. T. J. Dougherty C. J. Gomer B. W. Henderson G. Jori D. Kessel M. Korbelik J. Moan Q. Peng Photodynamic therapy J. Natl. Cancer Inst. 1998 90 889 905
2. D. Bechet P. Couleaud C. Frochot M. L. Viriot F. Guillemin M. Barberi-Heyob Nanoparticles as vehicles for delivery of photodynamic therapy agents Trends Biotechnol. 2008 26 612 621
3. M. E. Davis Z. G. Chen D. M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discovery 2008 7 771 782
4. D. Schrama R. A. Reisfeld J. C. Becker Antibody targeted drugs as cancer therapeutics Nat. Rev. Drug Discovery 2006 5 147 159
5. A. J. Bullous C. M. Alonso R. W. Boyle Photosensitiser-antibody conjugates for photodynamic therapy Photochem. Photobiol. Sci. 2011 10 721 750
6. D. Mew C. K. Wat G. H. Towers J. G. Levy Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates J. Immunol. 1983 130 1473 1477
7. B. Q. Spring A. O. Abu-Yousif A. Palanisami I. Rizvi X. Zheng Z. Mai S. Anbil R. B. Sears L. B. Mensah R. Goldschmidt S. S. Erdem E. Oliva T. Hasan Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates Proc. Natl. Acad. Sci. U. S. A. 2014 111 E933 E942
8. Y. Yarden M. X. Sliwkowski Untangling the ErbB signalling network Nat. Rev. Mol. Cell Biol. 2001 2 127 137
9. J. S. Ross J. A. Fletcher The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy Stem Cells 1998 16 413 428
10. D. J. Slamon B. Leyland-Jones S. Shak H. Fuchs V. Paton A. Bajamonde T. Fleming W. Eiermann J. Wolter M. Pegram J. Baselga L. Norton Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N. Engl. J. Med. 2001 344 783 792
11. T. Stuchinskaya M. Moreno M. J. Cook D. R. Edwards D. A. Russell Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates Photochem. Photobiol. Sci. 2011 10 822 831
12. J. Sudimack R. J. Lee Targeted drug delivery via the folate receptor Adv. Drug Delivery Rev. 2000 41 147 162
13. M. M. Qualls D. H. Thompson Chloroaluminum phthalocyanine tetrasulfonate delivered via acid-labile diplasmenylcholine-folate liposomes: intracellular localization and synergistic phototoxicity Int. J. Cancer Journal international du cancer 2001 93 384 392
14. C. S. Jin L. Cui F. Wang J. Chen G. Zheng Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy Adv. Healthc. Mater. 2014 3 1240 1249
15. D. Hogemann-Savellano E. Bos C. Blondet F. Sato T. Abe L. Josephson R. Weissleder J. Gaudet D. Sgroi P. J. Peters J. P. Basilion The transferrin receptor: A potential molecular imaging marker for human cancer Neoplasia 2003 5 495 506
16. M. R. Hamblin E. L. Newman Photosensitizer targeting in photodynamic therapy. I. Conjugates of haematoporphyrin with albumin and transferrin J. Photochem. Photobiol., B 1994 26 45 56
17. W. Arap R. Pasqualini E. Ruoslahti Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 1998 279 377 380
18. C. M. Allen W. M. Sharman C. La Madeleine J. M. Weber R. Langlois R. Ouellet J. E. van Lier Photodynamic therapy: tumor targeting with adenoviral proteins Photochem. Photobiol. 1999 70 512 523
19. J. Kopeček B. Říhová N. Krinick Targetable photoactivatable polymeric drugs J. Controlled Release 1991 16 137 143
20. M. Gary-Bobo Y. Mir C. Rouxel D. Brevet I. Basile M. Maynadier O. Vaillant O. Mongin M. Blanchard-Desce A. Morère M. Garcia J. O. Durand L. Raehm Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors Angew. Chem., Int. Ed. 2011 50 11425 11429
21. A. Weissenbock M. Wirth F. Gabor WGA-grafted PLGA-nanospheres: preparation and association with Caco-2 single cells J. Controlled Release 2004 99 383 392
22. G. Konska C. Vissac K. Zagla F. Chezet M. P. Vasson D. Bernard-Gallon J. Guillot Ultrastructural localization of binding sites for PNA and VVA-B(4) lectins in human breast cancer cell lines detected by confocal fluorescence microscopy Int. J. Oncol. 2002 21 1009 1014
23. G. F. Springer T and Tn, general carcinoma autoantigens Science 1984 224 1198 1206
24. G. Poiroux M. Pitié R. Culerrier B. Ségui E. J. Van Damme W. J. Peumans J. Bernadou T. Levade P. Rougé A. Barre H. Benoist Morniga G: a plant lectin as an endocytic ligand for photosensitizer molecule targeting toward tumor-associated T/Tn antigens Photochem. Photobiol. 2011 87 370 377
25. G. Obaid I. Chambrier M. J. Cook D. A. Russell Targeting the oncofetal Thomsen-Friedenreich disaccharide using jacalin-PEG phthalocyanine gold nanoparticles for photodynamic cancer therapy Angew. Chem., Int. Ed. 2012 51 6158 6162
26. L.-G. Yu J. D. Milton D. G. Fernig J. M. Rhodes Opposite effects on human colon cancer cell proliferation of two dietary Thomsen-Friedenreich antigen-binding lectins J. Cell. Physiol. 2001 186 282 287
27. B. A. Lindig M. A. J. Rodgers A. P. Schaap Determination of the lifetime of singlet oxygen in D2O using 9,10-anthracenedipropionic acid, a water-soluble probe J. Am. Chem. Soc. 1980 102 5590 5593
28. R. Bertrand E. Solary P. O'Connor K. W. Kohn Y. Pommier Induction of a Common Pathway of Apoptosis by Staurosporine Exp. Cell Res. 1994 211 314 321
29. A. A. Jeyaprakash P. G. Rani G. B. Reddy S. Banumathi C. Betzel K. Sekar A. Surolia M. Vijayan Crystal structure of the jacalin-T-antigen complex and a comparative study of lectin-T-antigen complexes J. Mol. Biol. 2002 321 637 645
30. L. J. Harris S. B. Larson K. W. Hasel A. McPherson Refined structure of an intact IgG2a monoclonal antibody Biochemistry 1997 36 1581 1597
31. D. C. Hone P. I. Walker R. Evans-Gowing S. FitzGerald A. Beeby I. Chambrier M. J. Cook D. A. Russell Generation of cytotoxic singlet oxygen via phthalocyanine-stabilized gold nanoparticles: A potential delivery vehicle for photodynamic therapy Langmuir 2002 18 2985 2987
32. M. E. Wieder D. C. Hone M. J. Cook M. M. Handsley J. Gavrilovic D. A. Russell Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: Cancer therapy using a 'Trojan horse' Photochem. Photobiol. Sci. 2006 5 727 734
33. L.-G. Yu L. C. Packman M. Weldon J. Hamlett J. M. Rhodes Protein phosphatase 2A, a negative regulator of the ERK signaling pathway, is activated by tyrosine phosphorylation of putative HLA class II-associated protein I (PHAPI)/pp32 in response to the antiproliferative lectin, jacalin J. Biol. Chem. 2004 279 41377 41383
34. H. Wang F. Wang X. Tao H. Cheng Ammonia-containing dimethyl sulfoxide: an improved solvent for the dissolution of formazan crystals in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay Anal. Biochem. 2012 421 324 326
35. F. Q. Schafer G. R. Buettner Singlet oxygen toxicity is cell line-dependent: a study of lipid peroxidation in nine leukemia cell lines Photochem. Photobiol. 1999 70 858 867
36. W. K. Kim M. H. Bang E. S. Kim N. E. Kang K. C. Jung H. J. Cho J. H. Park Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells J. Nutr. Biochem. 2005 16 155 162
37. H. Xu Y. Yu D. Marciniak A. K. Rishi F. H. Sarkar O. Kucuk A. P. Majumdar Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells Mol. Cancer Ther. 2005 4 435 442
38. A. Orlova M. Magnusson T. L. Eriksson M. Nilsson B. Larsson I. Hoiden-Guthenberg C. Widstrom J. Carlsson V. Tolmachev S. Stahl F. Y. Nilsson Tumor imaging using a picomolar affinity HER2 binding affibody molecule Cancer Res. 2006 66 4339 4348
39. Y. Tang J. Wang D. A. Scollard H. Mondal C. Holloway H. J. Kahn R. M. Reilly Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments Nucl. Med. Biol. 2005 32 51 58
40. M. J. Marín F. Galindo P. Thomas D. A. Russell Localized intracellular pH measurement using a ratiometric photoinduced electron-transfer-based nanosensor Angew. Chem., Int. Ed. 2012 51 9657 9661
41. R. Vacha F. J. Martinez-Veracoechea D. Frenkel Intracellular release of endocytosed nanoparticles upon a change of ligand-receptor interaction ACS Nano 2012 6 10598 10605
42. T. G. Iversen T. Skotland K. Sandvig Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies Nano Today 2011 6 176 185
43. S. Zhang J. Li G. Lykotrafitis G. Bao S. Suresh Size-Dependent Endocytosis of Nanoparticles Adv. Mater. 2009 21 419 424
44. C. A. Robertson D. H. Evans H. Abrahamse Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT J. Photochem. Photobiol., B 2009 96 1 8
45. P. Boya G. Kroemer Lysosomal membrane permeabilization in cell death Oncogene 2008 27 6434 6451
46. N. L. Oleinick H. H. Evans The photobiology of photodynamic therapy: cellular targets and mechanisms Radiat. Res. 1998 150 S146 S156